Regulating Effect of Cytochrome

Xin-Yi Tong, Xin-Zhi Yang, Shu-Qin Gao, Xiao-Juan Wang, Ge-Bo Wen, Ying-Wu Lin

Open access · goldAbstract read

In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

0.7field-weighted citation impact, top 33% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

Novel Perspective for Prognostic Stratification and Personalized Therapy in Breast Cancer Patients: Development of Cancer Stem Cells and Metabolism-Associated Prognostic Model.International journal of women's health · 2026
Article
CYB5A promotes osteogenic differentiation of MC3T3-E1 cells through autophagy mediated by the AKT/mTOR/ULK1 signaling pathway.Scientific reports · 2025
Article
Cytochrome b5 occurrence in giant and other viruses belonging to the phylum Nucleocytoviricota.Npj viruses · 2025
Article
The analysis of transcriptomic signature of TNBC-searching for the potential RNA-based predictive biomarkers to determine the chemotherapy sensitivity.Journal of applied genetics · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xin-Yi TongSchool of Chemistry and Chemical Engineering, University of South China, Hengyang 421001, China.

Xin-Zhi YangHengyang Medical College, University of South China, Hengyang 421001, China.

Shu-Qin GaoHengyang Medical College, University of South China, Hengyang 421001, China.

Xiao-Juan WangSchool of Chemistry and Chemical Engineering, University of South China, Hengyang 421001, China.

Ge-Bo WenHengyang Medical College, University of South China, Hengyang 421001, China.

Ying-Wu LinSchool of Chemistry and Chemical Engineering, University of South China, Hengyang 421001, China.ORCID 0000-0002-2457-0871

University of South China · CN

Funding

National Natural Science Foundation of China 21977042 and 32171270

6 · The paper itself

Abstract

Imbalance in the cellular redox system is thought to be associated with the induction and progression of breast cancers, and heme proteins may regulate the redox balance. Cytochrome

Indexed as

Breast NeoplasmsCytochromes b5FemaleHumansHydrogen PeroxideProto-Oncogene Proteins c-aktCYB5A protein, humanCytochromes b5Hydrogen PeroxideProto-Oncogene Proteins c-aktbreast cancer cellsco-immunoprecipitationCytochrome b5Cytochrome cprotein-protein interactions

Identifiers

PMID35889429

DOI10.3390/molecules27144556

PMCPMC9320672

OpenAlexW4285731819

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.